TABLE 2

Prognosis of acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) with mechanical ventilation: summary of studies published after 2008

First author [ref.], country (timeframe)NPatientsMethodsHospital survivalOverall survival
Yokoyama [44], Japan
(1998–2004)
11MV for AE-IPFNIV (IMV)
CPAP 10 cmH2O, PS/PEEP 5/10 cmH2O
45% (5/11)
3 month
45%
3 month
Mollica [46], Italy
(2000–2007)
34MV for ARF in ICUIMV or NIV
V T 7.5 mL·kg−1 or PS/PEEP 18/7 cmH2O
15% (5/34)3%
6 month
Güngör [47], Turkey
(2000–2007)
96MV for ARF in ICUIMV or NIV
V T 6–8 mL·kg−1, PEEP 5–7 cm H2O
36% (35/96)
Fernández-Pérez [45],
USA (2002–2006)
30MV for ARF in ICUIMV
V T 7–8 mL·kg−1
40% (12/30)
Gaudry [48], France
(2002–2009)
22MV for ARF in ICUIMV
V T 5.9 mL·kg−1, PEEP 7.1 cm H2O
23% (5/22)
ICU discharge
Vianello [49], Italy
(2005–2013)
18MV for ARF in ICUNIV (IMV)
V T 6–8 mL·kg−1, PEEP 6.4 cm H2O
14%
90 days
Total19333% (63/193)13%

MV: mechanical ventilation; NIV: noninvasive ventilation; IMV: invasive mechanical ventilation; CPAP: continuous positive pressure ventilation; PS: pressure support; PEEP: positive end-expiratory pressure; ARF: acute respiratory failure; ICU: intensive care unit; VT: tidal volume.